Scientific Publication

Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13)

author(s) Xu, C. - Li, R. - Shewade, H.D..
from UK Foreign, Commonwealth & Development Office (FCDO)
permalink open
themes
regions
  • Northern Europe
  • Europe
  • World
  • Eastern Asia
  • Asia
citation

Xu C, Li R, Shewade HD, Jeyashree K, Ruan Y, Zhang C, Wang L, Zhang H. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors. PLOS ONE. 2019;14(4):e0214943

Publications and datasets provided via GARDIAN

Abstract

China’s national tuberculosis programme does not have cohort wise information regarding attrition and delays in the multidrug resistant tuberculosis (MDR-TB) diagnosis and treatment pathway. Under the Global Fund programmatic management of drug-resistant TB (2006–13), the authors assessed the attrition and delay in the pathway and the factors associated. This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Open original